6
Feb
2020
Sanofi’s Intriguing MS Drug, Merck’s Big Spinoff & Coronavirus Fog
Lots of shiny blinking objects are out there to pay attention to, but this was a week when a lot of fundamental hard work got done in biotech. Read about it in Frontpoints. Deal of the Week Merck is spinning off women’s health, biosimilars, and “trusted legacy brands” into a new company. The unnamed NewCo rolls together products expected to... Read More
6
Feb
2020
CAR-T for Autoimmunity: Bluestone Joins Sonoma Biotherapeutics, a $40M Bet
Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $169 per year, you reward quality independent biotech reporting, and encourage more. Subscribe Now Sign in to your account.